505 related articles for article (PubMed ID: 12032779)
21. IFN-alpha enhances TNF-alpha-induced apoptosis through down-regulation of c-Myc protein expression in HL-60 cells.
Nakashima A; Kumakura S; Mishima S; Ishikura H; Kobayashi S
J Exp Clin Cancer Res; 2005 Sep; 24(3):447-56. PubMed ID: 16270532
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic signaling by c-MYC.
Hoffman B; Liebermann DA
Oncogene; 2008 Oct; 27(50):6462-72. PubMed ID: 18955973
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
24. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
25. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
Packham G; Cleveland JL
Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
[TBL] [Abstract][Full Text] [Related]
26. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
28. The c-myc apoptotic response is not intrinsic to blocking terminal myeloid differentiation.
D'Angelo S; Liebermann D; Hoffman B
J Cell Physiol; 2008 Jul; 216(1):120-7. PubMed ID: 18247372
[TBL] [Abstract][Full Text] [Related]
29. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
[TBL] [Abstract][Full Text] [Related]
30. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
32. Integrated control of cell proliferation and cell death by the c-myc oncogene.
Evan G; Harrington E; Fanidi A; Land H; Amati B; Bennett M
Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):269-75. PubMed ID: 7846125
[TBL] [Abstract][Full Text] [Related]
33. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
34. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
35. Role of myc amplification and overexpression in cell growth, differentiation and death.
Koskinen PJ; Alitalo K
Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
[TBL] [Abstract][Full Text] [Related]
36. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
Habel ME; Lemieux R; Jung D
J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
[TBL] [Abstract][Full Text] [Related]
38. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
39. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
40. Phenotypes and mechanisms in the transformation of hematopoietic cells.
Ihle JN; Morishita K; Bartholomew C; Matsugi T; Askew D
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():130-46. PubMed ID: 2109024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]